Mariëtte B. van Ravenhorst

Author

Wilhelmina Children's Hospital ORCID

Also Known As

M.B. van Ravenhorst, Mariette B. van Ravenhorst, Mariëtte B van Ravenhorst, Mariëtte B. van Ravenhorst

Publications

230

Citations

H-Index

Concepts

All Affiliations

Wilhelmina Children's Hospital University Medical Center Utrecht National Institute for Public Health and the Environment Amsterdam UMC Location Vrije Universiteit Amsterdam

About

Mariëtte B. van Ravenhorst is an author at Wilhelmina Children's Hospital specializing in vaccination, infection control, and bacterial meningitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	78
2	Immunology	3	3	78
3	Bacterial Meningitis	3	3	78
4	Vaccine Development	2	2	58
5	Epidemiology	1	1	20

Mariëtte B. van Ravenhorst

Publications

205

Citations

H-Index

Page 1

	Year	Citations
Use of saliva to monitor meningococcal vaccine responses: proposing a threshold in saliva as surrogate of protection Mariëtte B. van Ravenhorst, Fiona van der Klis, Debbie M. van Rooijen, BMC Medical Research Methodology	2019	53
Meningococcal carriage in Dutch adolescents and young adults; a cross-sectional and longitudinal cohort study Mariëtte B. van Ravenhorst, Merijn W. Bijlsma, Marlies A. van Houten, Clinical Microbiology and Infection	2017	38
Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial Mariëtte B. van Ravenhorst, Fiona van der Klis, Debbie M. van Rooijen, Vaccine VaccinationVaccine DevelopmentAntibody PersistenceMemory B-cellsImmunology	2017	34
Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination Mariëtte B. van Ravenhorst, Fiona van der Klis, Debbie M. van Rooijen, Vaccine VaccinationVaccinologyQuadrivalent Meningococcal AVaccine DevelopmentImmunology	2017	24
Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination Mariëtte B. van Ravenhorst, Axel Bonačić Marinović, Fiona van der Klis, Vaccine VaccinationVaccine SafetyProtective AntibodiesMedicineImmunology	2016	20
Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, W and Y conjugate vaccine Mariëtte B. van Ravenhorst, Gerco den Hartog, Fiona van der Klis, PLoS ONE	2018	19
Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection Saskia van der Lee, Susanne P. Stoof, Mariëtte B. van Ravenhorst, Eurosurveillance	2017	17

Page 1